Omega-3 Index: A Better Mortality Predictor Than Cholesterol

The $50 Blood Test That Predicts Your Death Better Than Cholesterol. And Almost Nobody Is Ordering It.

A biomarker validated by researchers at Stanford, Harvard, Tufts, and Ludwig Maximilians University Munich. Cited in over 700 peer-reviewed research papers. Recognized as the most widely used omega-3 status test in the world.

You will almost certainly not find it on your last lab report.

This is the story of the Omega-3 Index. It is a story about science, mortality, and the strange gap between what the research community has known for two decades and what your doctor is ordering at your annual physical.

It also raises an uncomfortable question. If a $50 test predicts your risk of dying better than the cholesterol panel that has been the bedrock of preventive cardiology for 50 years, why is nobody running it?

Could it possibly be that there is more money in treating disease than in measuring the nutrient deficiency that helps cause it?

Surely not. Let us look at the data.

What Is the Omega-3 Index?

The Omega-3 Index is the percentage of EPA and DHA omega-3 fatty acids in your red blood cell membranes. It reflects your long-term omega-3 status, similar to how hemoglobin A1C reflects your long-term blood sugar.

A finger prick blood test gives you a number. The desirable range is 8 to 12 percent. Most Americans sit at 4 to 5 percent. The optimal zone for cardiovascular and brain health is 8 percent or higher.

The test was developed by Dr. William Harris, a lipid researcher with 40 years in the field, and Dr. Clemens von Schacky, a preventive cardiologist at Ludwig Maximilians University in Munich, Germany. They proposed it in 2004 as a new risk factor for sudden cardiac death.

Two decades of subsequent research has confirmed they were right.

How Does the Omega-3 Index Compare to Cholesterol as a Risk Predictor?

In the landmark 2018 Framingham Heart Study analysis, the Omega-3 Index was significantly associated with mortality. Total cholesterol was not.

Read that twice.

Researchers followed 2,500 participants from the Framingham Offspring cohort. After adjusting for age, sex, blood pressure, smoking, and other risk factors, participants in the highest Omega-3 Index quintile had a 34 percent lower risk of death from any cause and a 39 percent lower risk for incident cardiovascular disease compared to those in the lowest quintile.

When researchers compared total cholesterol and Omega-3 Index in the same statistical models, the Omega-3 Index was significantly related to outcomes. Total cholesterol was not.

That is not a minor finding. That is the entire foundation of conventional cardiovascular risk assessment getting outperformed by a biomarker most physicians have never heard of.

A 2021 follow-up study by McBurney and colleagues, using the same Framingham cohort, went further. Dr. Bill Harris summarized the finding bluntly: the information carried in red blood cell fatty acid concentrations was as useful as that carried in lipid levels, blood pressure, smoking status, and diabetic status combined when it came to predicting total mortality.

Translation: a low Omega-3 Index is as powerful a predictor of early death as smoking.

Key Findings on Omega-3 Index vs. Cholesterol

Is This Just One Lab Promoting Its Own Test?

This is the most common pushback. And it deserves a direct answer.

Yes, Dr. Bill Harris founded OmegaQuant Analytics, the lab that commercialized the Omega-3 Index test. Yes, he holds stock in that company. Both facts are openly disclosed in every paper he publishes.

But this is not a one-man operation marketing its own product. The science behind the Omega-3 Index has been validated by a global consortium of researchers who have no financial stake in OmegaQuant, working at institutions with reputations far older and larger than any single lab.

Consider the actual roster of scientists publishing on omega-3 biomarkers as a predictor of mortality and disease:

The Scientific Community Behind the Omega-3 Index

This is not Bill Harris alone. This is Stanford, Harvard, Tufts, Brigham and Women's Hospital, Mass General, the University of Washington, Ludwig Maximilians University Munich, the University of Cambridge, and dozens of other institutions independently arriving at the same conclusion across thousands of participants and decades of follow-up data.

The original 2004 paper by Harris and von Schacky has been cited in over 700 research papers. A 2025 review in Current Opinion in Clinical Nutrition and Metabolic Care confirmed that 58 new citations of the Omega-3 Index appeared in PubMed in the previous 18 months alone.

That is not a fringe concept. That is institutional adoption.

What Do the Largest Studies Actually Show?

The validation extends across the most rigorous study designs available in nutrition epidemiology.

A 2016 pooled analysis published in JAMA Internal Medicine, led by Del Gobbo and Mozaffarian, combined 19 prospective cohort studies with 45,637 participants from 16 countries. They examined blood-based omega-3 biomarkers and risk of coronary heart disease. The conclusion: higher levels of EPA, DPA, and DHA were associated with lower risk of fatal coronary heart disease.

A 2021 pooled analysis of 17 prospective cohort studies, published in Nature Communications, found that risk for death from all causes was 15 to 18 percent lower in the highest versus the lowest quintile for circulating long-chain omega-3 fatty acids.

A 2025 systematic review and meta-analysis in Clinical and Translational Discovery analyzed 42 studies covering 176,253 participants. Omega-3 fatty acids were associated with significant reductions in cardiovascular mortality, coronary heart disease, myocardial infarction, fatal myocardial infarction, and revascularization.

A 2025 meta-analysis in the Journal of Clinical Medicine confirmed omega-3 fatty acids as predictors of sudden cardiac death and cardiovascular mortality.

A 2017 estimate from 10 cohort studies, led by Harris, Del Gobbo, and Tintle, calculated that risk for fatal coronary heart disease would be reduced by approximately 30 percent moving from an Omega-3 Index of 4 percent to 8 percent.

These are not small trials. These are pooled global datasets. The signal is consistent across continents, populations, and decades.

How Does the Omega-3 Index Protect the Brain?

This is where the conversation expands beyond the heart and into Healthy Rant's Brain Health pillar.

DHA makes up over 90 percent of the omega-3 fatty acids in the human brain. It is concentrated in the gray matter responsible for thinking, memory, and processing.

A 2022 Framingham Heart Study analysis published in Neurology found that higher red blood cell omega-3 levels were associated with better brain structure and cognitive function in adults aged 40 to 60. The researchers concluded that omega-3 intake at midlife may already be protecting the brain against most of the indicators of aging seen in later decades.

A 2025 dose-response meta-analysis published in Scientific Reports (Nature portfolio) identified an optimal omega-3 supplementation range of 1,000 to 2,500 mg per day for cognitive function.

A 2025 study published in the Journal of Lipid Research showed that long-term omega-3 supplementation in mice reduced the accumulation of phosphorylated tau and amyloid-beta in the brain. Those are the two signature proteins of Alzheimer's disease.

Dr. David Perlmutter, neurologist and author, has spent his career arguing that omega-3 status is among the most important modifiable risk factors for cognitive decline. The research supports him.

What About Inflammation, Longevity, and Cellular Aging?

This is where Dr. Rhonda Patrick's enthusiasm becomes contagious, and the science behind it is genuinely remarkable.

Your body converts EPA and DHA into a family of resolution molecules called specialized pro-resolving mediators, or SPMs. These include resolvins, protectins, and maresins. They do not suppress inflammation the way NSAIDs do. They orchestrate its cleanup.

When inflammation cannot resolve, it becomes chronic. Chronic inflammation is the root driver of atherosclerosis, metabolic syndrome, neurodegeneration, and most age-related disease.

Rhonda Patrick puts it directly: "Omega-3s are resolving inflammation, blunting inflammation, and they affect so many different parts of the inflammatory pathway. It plays a huge role in the way we age, the way our brain ages, the way we feel, our mood, our joints, all that."

She maintains her own Omega-3 Index above 8 percent and takes approximately 2,000 to 2,400 mg of combined EPA and DHA daily.

And then there is the telomere data. Telomeres are the protective caps at the ends of your chromosomes. Their shortening is one of the established hallmarks of aging defined in the landmark 2013 Cell paper by López-Otín and colleagues. A 2022 meta-analysis of clinical trials found that omega-3 fatty acids exert a beneficial effect on telomere length.

You are quite literally aging at the cellular level based partially on your omega-3 status.

Why Isn't Your Doctor Ordering This Test?

Now we arrive at the uncomfortable question.

Two decades of peer-reviewed research. Stanford. Harvard. Tufts. Mass General. The Framingham Heart Study. JAMA Internal Medicine. Nature Communications. Circulation. The American Journal of Clinical Nutrition. A biomarker that outperforms cholesterol as a mortality predictor. A test that costs about $50.

And yet your annual physical includes a lipid panel that the research suggests is less predictive than this overlooked metric. Your doctor will measure your LDL down to the milligram and dutifully prescribe a statin if it crosses an arbitrary threshold. But ask about your Omega-3 Index and you will likely get a blank stare.

Why?

A few honest possibilities.

First, medical school curricula change slowly. Most physicians practicing today completed their training before the Omega-3 Index had a substantial evidence base. Continuing medical education is voluntary for most concepts that do not have a pharmaceutical company pushing them through dinner presentations.

Second, there is no pharmaceutical product to sell on the back of an Omega-3 Index test. A statin is a patentable molecule with a 90 billion dollar annual market. EPA and DHA are nutrients you can buy at any grocery store for $20. There is no sales rep visiting your doctor's office with a pamphlet about fish.

Third, the entire conventional cardiology paradigm has been built around cholesterol for half a century. Pivoting to acknowledge that a different biomarker might be more predictive is a significant institutional admission. Institutions resist that kind of pivot.

Could it be profit over root cause?

You decide.

Medicine 2.0 waits for disease to show up and then treats the symptom. Medicine 3.0 measures the deficiency that helps cause the disease and corrects it before the symptom appears.

The Omega-3 Index is Medicine 3.0 in a finger-prick package. And almost nobody is ordering it.

What Should You Actually Do?

You do not need permission from a healthcare system that is structurally disincentivized to measure root causes. You can order the test yourself.

A Practical Omega-3 Action Plan

I Tested. Here Is My Number.

I do not write about anything I have not tested on myself first.

My most recent Omega-3 Index came back at 13.76 percent.

[INSERT IMAGE: OmegaQuant Omega-3 Index Basic Report showing 13.76 percent result]

That puts me above the 8 to 12 percent desirable range. For context, the average American sits at 4 to 5 percent. The research suggests that someone at my level carries a 34 percent lower risk of all-cause mortality and a 39 percent lower risk of cardiovascular disease compared to someone at the population average.

That is not theory. That is a number on an actual lab report from a CLIA-certified facility, ordered without a physician referral, returned in nine days, for less than the cost of a tank of gas.

You can do exactly the same thing.

Test Your Omega-3 Index Today

Stop guessing. Measure.

The same lab I used is available to you directly. OmegaQuant Analytics is the CLIA-certified facility founded by Dr. Bill Harris, the researcher who invented the Omega-3 Index. The test ships to your door. You collect a single drop of blood with a finger prick. You return it in a prepaid envelope. You get your number in about a week.

[ORDER YOUR OMEGA-3 INDEX TEST AT OMEGAQUANT.COM] 

You cannot manage what you do not measure. Get your number. Then make decisions based on data, not on whatever your insurance company decided to cover at your last physical.

Key Takeaways

The Omega-3 Index measures EPA and DHA as a percentage of red blood cell fatty acids. It reflects long-term omega-3 status, similar to hemoglobin A1C for glucose.

In the Framingham Heart Study, the Omega-3 Index predicted mortality. Total cholesterol did not.

Validation comes from a global network of researchers at Stanford, Harvard, Tufts, Mass General, the University of Washington, Ludwig Maximilians University Munich, and the University of Cambridge. This is not one lab promoting its own test.

Pooled analyses across hundreds of thousands of participants confirm the same pattern. Higher omega-3 status equals lower risk of cardiovascular death, sudden cardiac death, cognitive decline, and all-cause mortality.

The Omega-3 Index test costs about $50 and is available direct to consumers at OmegaQuant.com. The conventional medical system, optimized to treat disease rather than measure the deficiencies that cause it, has not adopted it.

You can.

Decline is not inevitable.

Continue Learning

Healthy Rant covers five pillars of preventative health: Metabolic Health, Exercise Physiology, Brain Health, Longevity, and Preventative Nutrition. The Omega-3 Index touches four of them.

For weekly research updates, protocols, and the kind of root-cause analysis the medical establishment has decided is not worth the time, subscribe to The Independence Standard newsletter at healthyrant.com/independence-standard.html.

Citations

This article is for educational purposes and is not medical advice. Always consult a qualified healthcare provider before making changes to your nutrition or supplementation protocol.